Cardiovascular Medicine

5 pages, 2279 KB

Open AccessCommunication

by Ruth Amstein, Frank Enseleit and Thomas F. Lüscher

Cardiovasc. Med. 2009, 12(2), 60; https://doi.org/10.4414/cvm.2009.01395 - 20 Feb 2009

Viewed by 34

CARTA, der «Cardiovascular Roundtable» zwischen führenden Vertretern der kardiovaskulären Medizin, der Pharmaund Medizinaltechnikindustrie sowie der Gesundheits- und Bildungspolitik [...] Full article

► Show Figures

Figure 1

3 pages, 97 KB

Open AccessEditorial

TAKE CAKE oder PAKE? - Perkutaner Aortenklappenersatz in der Schweiz

by Johannes Jehle, Hans Rickli and Jens P. Hellermann

Cardiovasc. Med. 2009, 12(2), 57; https://doi.org/10.4414/cvm.2009.01393 - 20 Feb 2009

Viewed by 29

Abstract

Quelle
Descoutures F, Vahanian A, et al. Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly [...] Full article

► Show Figures

Figure 1

4 pages, 1775 KB

Open AccessInteresting Images

Jailbreak of a Guide Wire Imprisoned by One Underexpanded Coronary Stent: The Serendipitous Crushing Technique

by Yassine Bouatou and Stéphane Cook

Cardiovasc. Med. 2009, 12(2), 53; https://doi.org/10.4414/cvm.2009.01394 - 20 Feb 2009

Viewed by 32

Abstract

We report a case of percutaneous coronary intervention complicated by guide wire entrapment secondary to incidental stent crushing after unprompted stent recoil. The guide wire could be successfully removed together with the stent by contraction of the latter [...] Full article

► Show Figures

Figure 1

2 pages, 180 KB

Open AccessInteresting Images

Infarctus inférieur aigu: Quelle artère faut-il dilater?

by Jürg Schläpfer

Cardiovasc. Med. 2009, 12(2), 51; https://doi.org/10.4414/cvm.2009.01397 - 20 Feb 2009

Viewed by 32

Abstract

Description du cas
ECG d’un patient hospitalisé en urgence pour infarctus aigu. Rythme sinusal à 88/min [...] Full article

► Show Figures

Figure 1

6 pages, 825 KB

Open AccessEditorial

Emboli Protection Devices in Cardiovascular Medicine

by Marco Roffi

Cardiovasc. Med. 2009, 12(2), 45; https://doi.org/10.4414/cvm.2009.01390 - 20 Feb 2009

Viewed by 27

Abstract

Emboli protection devices (EPD) have a solid stand in the modern armamentarium of the interventionalist. However, the use of these devices is associated with a broad range of benefits in different cardiovascular territories. The most compelling data for mechanical emboli protection are available [...] Read more.

Emboli protection devices (EPD) have a solid stand in the modern armamentarium of the interventionalist. However, the use of these devices is associated with a broad range of benefits in different cardiovascular territories. The most compelling data for mechanical emboli protection are available for percutaneous interventions of aortocoronary bypass grafts. In this setting, randomised studies have shown that the use of EPD is associated with a significant reduction in major adverse events. Nevertheless, current registry data suggest that the devices are used only in a minority of those cases. Conversely, in acute myocardial infarction, the routine use of EPD was not found to be beneficial. A strong consensus, though not unanimous, supports the use of these devices for carotid artery stenting. With respect to renal stenting, the experience is still at an early stage and the use of EPD cannot be recommended. Full article

► Show Figures

Figure 1

7 pages, 339 KB

Open AccessProceeding Paper

Adults with Congenital Heart Defect—Quo Vadis

by Noémi D. Stoutz and Marcia Leventhal

Cardiovasc. Med. 2009, 12(2), 38; https://doi.org/10.4414/cvm.2009.01392 - 20 Feb 2009

Cited by 1 | Viewed by 26

Abstract

Introduction: Up to 1% of newborns present with a congenital heart defect: Due to improved management of their conditions a growing number of these patients reach adulthood. They require lifelong care, including qualified end of life care. Objectives and methods: The [...] Read more.

Introduction: Up to 1% of newborns present with a congenital heart defect: Due to improved management of their conditions a growing number of these patients reach adulthood. They require lifelong care, including qualified end of life care. Objectives and methods: The authors reviewed the literature for answers to the following questions: Is there a knowledge base relevant to palliative care (PC) in the cardiology literature? Is it likely that the irreversibility of the progression towards death will be diagnosed and that the adults with congenital heart defects (ACHD) will be appropriately informed as soon as this stage is identified? Are there algorithms for the control of the physical symptoms which divert patients from the creative act of living the last chapter of their biography? How do healthcare teams plan to support the patients’ loved ones? Will their needs for bereavement follow-up care be met? Results: We identified PC issues and found many cardiology publications addressing these issues, although much of the research was not expressly done in view of end of life care. The relevant cardiology literature was compared to the PC literature to explore the availability of PC expertise in cardiology. A lack of awareness rather than of knowledge seems to be the cause of unsatisfactory provision of PC. Networking with existing PC services may fill these gaps. Conclusions: Much still needs to be done in the next years. Research and education are necessary to empower multiprofessional cardiology teams to ensure that total care is available for the cardiac patients and their families throughout the course of the illness, and through death to bereavement care. A good life needs a good ending, and that is a challenge for our health care teams. Full article

► Show Figures

Figure 1

5 pages, 594 KB

Open AccessEditorial

Herzrhythmusstörungen in der Klinik: Entscheidungsfindung zur Intervention jenseits existierender Richtlinien

by Thomas A. Cron and Beat Schaer

Cardiovasc. Med. 2009, 12(2), 33; https://doi.org/10.4414/cvm.2009.01391 - 20 Feb 2009

Viewed by 25

Abstract

Arrhythmias in clinical practice: Decision-making beyond guidelines. Therapy guidelines should support the physician to take correct decisions in treating his patients. However, in certain situations such guidelines offer no help, either because they are not applicable to the given patient or because [...] Read more.

Arrhythmias in clinical practice: Decision-making beyond guidelines. Therapy guidelines should support the physician to take correct decisions in treating his patients. However, in certain situations such guidelines offer no help, either because they are not applicable to the given patient or because there is a lack of evidence even for common clinical problems. Referring to recently published data, two situations with difficult decision making will be discussed. During follow-up of pacemaker or defibrillatordevices, atrial tachyarrhythmias (AT/AF) can be documented. In these cases the question arises if antithrombotic prophylaxis is needed. In the TRENDS study, patients with an “AT/AF-burden” of more than 5.5 hours/day had a significant higher risk of thromboembolic events. Thus in these patients anticoagulation might be indicated after careful evaluation of their corresponding risk factors. In a subanalysis of the MADIT-II trial, a clinical risk score was created to investigate the survival benefit of ICD-implantation for primary prevention in different risk groups. The results indicate that risk groups can be identified, where the benefit of the ICD-therapy can be limited. In another study the importance of continuous risk assessment was highlighted, as the so-called “competing risk”, i.e. death prior to ever using the device, is not negligible. Full article

► Show Figures

Figure 1

Journal Menu

Journal Browser

Cardiovasc. Med., Volume 12, Issue 2 (02 2009) – 7 articles

Further Information

Guidelines

MDPI Initiatives

Follow MDPI